Skip to main content
SpringerLink
Log in

Prevalence of QT-prolonging drugs in elderly patients with dementia

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Gustafsson M, et al. Prevalence of Drugs and Drug Combinations that Increase Risk of Prolonged QT Time Among People with Major Neurocognitive Disorder Living in Sweden: A Cross-Sectional Registry Study Drugs - Real World Outcomes : 22 Nov 2022. Available from: URL: https://doi.org/10.1007/s40801-022-00341-3

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prevalence of QT-prolonging drugs in elderly patients with dementia. Reactions Weekly 1934, 9 (2022). https://doi.org/10.1007/s40278-022-28390-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-28390-9

Search

Navigation